{"id":"tp-38014","type":"article-newspaper","title":"Injective and BDACS Name KRW1 as Planned Sole Won Settlement Asset","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/38014","datePublished":"2026-10-22T15:25:33.000Z","dateModified":"2026-10-22T15:25:33.000Z","language":"en","abstract":"The memorandum limits minting and redemption on Injective to approved institutional partners and makes both actions subject to regulatory approval.","section":"Business","references":[]}